Literature DB >> 16177125

Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections.

Smita Y Patel1, Li Ding, Margaret R Brown, Larry Lantz, Ted Gay, Stuart Cohen, Lenna A Martyak, Bernard Kubak, Steven M Holland.   

Abstract

Although many patients with disseminated nontuberculous mycobacterial disease have molecular defects in the IFN-gamma/IL-12 axis, recent case reports have shown autoantibodies against IFN-gamma associated with severe nontuberculous mycobacterial infections. To check this finding in an independent population, we screened 35 patients with either disseminated or pulmonary nontuberculous mycobacterial infections for whom no molecular defect was known. We identified high-titer-neutralizing anti-IFN-gamma IgG in the plasma of six patients. All six patients were female, parous, of East Asian descent, and had disseminated infection, predominantly with rapidly growing mycobacteria. The anti-IFN-gamma IgG had in vitro biological activity on the IFN-gamma-dependent phosphorylation of STAT-1 as well as on the IFN-gamma-dependent up-regulation of TNF-alpha and IL-12. In contrast, this anti-IFN-gamma Ab had no effect on IFN-alpha-dependent STAT-1 phosphorylation. These patients confirm a novel syndrome linking autoimmunity and immunodeficiency.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16177125     DOI: 10.4049/jimmunol.175.7.4769

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  80 in total

1.  Anti-CD20 (rituximab) therapy for anti-IFN-γ autoantibody-associated nontuberculous mycobacterial infection.

Authors:  Sarah K Browne; Rifat Zaman; Elizabeth P Sampaio; Kamonwan Jutivorakool; Lindsey B Rosen; Li Ding; Minjal J Pancholi; Lauren M Yang; Debra Long Priel; Gulbu Uzel; Alexandra F Freeman; Carlton E Hayes; Roger Baxter; Stuart H Cohen; Steven M Holland
Journal:  Blood       Date:  2012-03-08       Impact factor: 22.113

2.  Determination of human anticytokine autoantibody profiles using a particle-based approach.

Authors:  Li Ding; Allen Mo; Kamonwan Jutivorakool; Minjal Pancholi; Steven M Holland; Sarah K Browne
Journal:  J Clin Immunol       Date:  2011-12-06       Impact factor: 8.317

3.  Can primary immunodeficiencies help to provide insights into infectious risks of therapeutic antibodies?

Authors:  László Maródi; Jean-Laurent Casanova
Journal:  Nat Rev Immunol       Date:  2010-05       Impact factor: 53.106

Review 4.  Adult-onset presentations of genetic immunodeficiencies: genes can throw slow curves.

Authors:  Katharine S Nelson; David B Lewis
Journal:  Curr Opin Infect Dis       Date:  2010-08       Impact factor: 4.915

5.  Late-Onset Disseminated Mycobacterium avium intracellulare Complex Infection (MAC), Cerebral Toxoplasmosis and Salmonella Sepsis in a German Caucasian Patient with Unusual Anti-Interferon-Gamma IgG1 Autoantibodies.

Authors:  Leif G Hanitsch; Madlen Löbel; Holger Müller-Redetzky; Mariana Schürmann; Norbert Suttorp; Nadine Unterwalder; Ulrike Mönnich; Christian Meisel; Kirsten Wittke; Hans-Dieter Volk; Carmen Scheibenbogen; Uwe Kölsch
Journal:  J Clin Immunol       Date:  2015-04-15       Impact factor: 8.317

6.  Recurrent Burkholderia gladioli suppurative lymphadenitis associated with neutralizing anti-IL-12p70 autoantibodies.

Authors:  Bich-Thuy T Sim; Sarah K Browne; Marguerite Vigliani; Dalila Zachary; Lindsey Rosen; Steven M Holland; Steven M Opal
Journal:  J Clin Immunol       Date:  2013-05-26       Impact factor: 8.317

7.  Natural History and Evolution of Anti-Interferon-γ Autoantibody-Associated Immunodeficiency Syndrome in Thailand and the United States.

Authors:  Gloria H Hong; Ana M Ortega-Villa; Sally Hunsberger; Ploenchan Chetchotisakd; Siriluck Anunnatsiri; Piroon Mootsikapun; Lindsey B Rosen; Christa S Zerbe; Steven M Holland
Journal:  Clin Infect Dis       Date:  2020-06-24       Impact factor: 9.079

8.  Importance of T cells, gamma interferon, and tumor necrosis factor in immune control of the rapid grower Mycobacterium abscessus in C57BL/6 mice.

Authors:  Martin Rottman; Emilie Catherinot; Patrick Hochedez; Jean-François Emile; Jean-Laurent Casanova; Jean-Louis Gaillard; Claire Soudais
Journal:  Infect Immun       Date:  2007-09-17       Impact factor: 3.441

9.  Identification of a major epitope by anti-interferon-γ autoantibodies in patients with mycobacterial disease.

Authors:  Chia-Hao Lin; Chih-Yu Chi; Han-Po Shih; Jing-Ya Ding; Chia-Chi Lo; Shang-Yu Wang; Chen-Yen Kuo; Chun-Fu Yeh; Kun-Hua Tu; Shou-Hsuan Liu; Hung-Kai Chen; Chen-Hsuan Ho; Mao-Wang Ho; Chen-Hsiang Lee; Hsin-Chin Lai; Cheng-Lung Ku
Journal:  Nat Med       Date:  2016-08-15       Impact factor: 53.440

10.  Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I.

Authors:  Anne Puel; Rainer Döffinger; Angels Natividad; Maya Chrabieh; Gabriela Barcenas-Morales; Capucine Picard; Aurélie Cobat; Marie Ouachée-Chardin; Antoine Toulon; Jacinta Bustamante; Saleh Al-Muhsen; Mohammed Al-Owain; Peter D Arkwright; Colm Costigan; Vivienne McConnell; Andrew J Cant; Mario Abinun; Michel Polak; Pierre-François Bougnères; Dinakantha Kumararatne; László Marodi; Amit Nahum; Chaim Roifman; Stéphane Blanche; Alain Fischer; Christine Bodemer; Laurent Abel; Desa Lilic; Jean-Laurent Casanova
Journal:  J Exp Med       Date:  2010-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.